A new form of RNA polymerase, termed RNA polymerase 111, has been recognized as a large fraction of the rifampicin-sensitive enzyme in E. coli. It is physically separable from RNA polymerase (holoenzyme, RNA polymerase I) by gel filtration and is distinguished by its capacity to discriminate between M13 and 4x174 viral DNA templates in priming DNA synthesis. This template specificity is manifested only with saturating levels of DNA unwinding protein and characterizes the priming of DNA synthesis on viral single strands in cell-free extracts and in vivo. RNA polymerase 111 has less than 5% of the specific activity of RNA polymerase 1 in transcribing duplex DNA of phages X and T4, salmon sperm DNA, and the copolymer poly[d(A-T)). Rifampicin inactivation of RNA polymerase 111 releases a factor, presumably a small subunit, which can be isolated and used to confer on RNA polymerase I the properties of 111, namely, discrimination between M13 and 6x174 templates in priming DNA synthesis, and a relative inability to transcribe duplex DNA.
The observation that rifampicin, a specific inhibitor of the &subunit of bacterial RNA polymerase, blocks conversion of MI3 single-stranded circular viral DNA (SS) to the duplex replicative form (RF) i n vi00 first led us to postulate a role for RNA priming in DNA synthesis (1). Silverstein and Billen (2) found that conversion of dX174 SS to R F was not sensitive to rifampicin under similar conditions. Soluble extracts of gently lysed Escherichia coli, like the intact cells, were rifampicin-sensitive in the conversion of SS to RF of M13, but not of 6x174 (3). Further studies (4, 5, 20) have shown that replication of 4x174 SS is primed by a multienzyme RNA synthetic system using many of the same factors required for host chromosome replication. Recently, reconstitution of M13 SS to RF has been achieved (6) with purified DNA polymerase 111 holoenzyme (7), DNA unwinding protein (8, 9), and RNA polymerase I (holoenzyme). These enzymes resemble cells and crude extracts in producing M13 R F with a full-length linear complementary strand and a unique gap (3, 6), but they have the nonphysiological p r o p erty of catalyzing rifampicin-sensitive conversion of .$X SS to RF.
A search for the enzymatic basis of M13 DNA-specific priming has led us to purify a new form of RNA polymerase, termed RNA polymerase 111, the subject of this communication. This enzyme is assayed by its ability, in the presence of DNA unwinding protein, to prime DNA polymerase I11 holoenzyme replication of M13, but not 4X, DNA. RNA polymerase 111, purified approsimately 100-fold by ammonium sulfate fractionation and gel filtration, is estimated to be 50% pure by sodium dodecyl sulfate-acrylamide gel analysis.
Abbreviations: SS, single-stranded circular viral DNA; RF, double-atranded, circular viral DNA; 6X, bacteriophage 6x174.
It is separated from RNA polymerase I during gel filtration.
In addition to its selectivity in priming DNA synthesis, it is distinguished from RNA polymerases I and I1 by the remarkable property of being inactive in transcription of duplex DNA under RNA polymerase I assay conditions. Upon exposure to rifampicin, a small factor is released from RNA polymerase 111 which renders RNA polymerase I (holoenzyme) both template-specific in priming viral DNA synthesis and inactive in transcribing duplex DNA. These studies raise questions about the physiological role of RNA polymerase 111, its structure and interconversion with RNA polymerase I, and the role of each in the RNA synthetic events of the cell.
MATERIALS AND METHODS
Materials were from previously described sources (7). E. coli B, harvested */, through the logarithmic phase of growth on rich medium, was purchased from Grain Processing Corp., Muscatine, Iowa.
Enzymes. DNA polymerase 111 holoenzyme was prepared as described (7). DNA unwinding protein was prepared according to Weiner et al. (9) . We thank Dr. Michael Chamberlin for gifts of RNA polymerase I holoenzyme and core (IO) as well as for rifampicin-resistant holoenzyme. tinless otherwise noted, RNA polymerase I was prepared by a minor modification of the method of 13abinet (11).
Templates. M13 and $XI74 SS were prepared as described previously (12). Salmon sperm DNA was purchased from Sigma. Phage T4 and X DNAs were the generous gifts of Dr. J. Thorner to a final volume of 25 pl. After a 10-min incubation at 30", acid-insoluble nucleotide was determined (13). One unit of RNA polymerase I11 primes 1 nmole of deoxynucleotide incorporation into M13 R F per rnin a t 30'. RNA synthesis was measured in a volume of 50 pl containing: 0.05 M Tris-HCl (pH 7.5), 0.4 mg/ml of bovine serum albumin, 4 mM Zmercaptoethanol, 15 mM MgCl,, 1 mM ['HIATP (10' cpm/pmole), 1 mM each of GTP, CTP, and UTP, and 25 pgjml of DNA template. Acid-insoluble nucleotide was measured after 10 min at 30".
RESULTS

Purification of R N A Polymerase I I I . All operations were a t
Preparation of Extract. Two hundred grams of frozen E. coli 13 cell paste (see Materials and Methods) was broken into small pieces and placed in a 1-liter Waring Blendor. Lysis buffer [lo% sucrose, 0.05 M Tris.HC1 (pH 7,5), 0.2 M ammonium sulfate, and 10 mM spermidine-HCl] was added to the suspension to a volunie of one liter and the cells were suspended with three full-power bursts. Lysozyme (100 mg) was added and the suspension was immediately transferred to five 250-ml plastic bottles placed on ice. After 30 rnin the bottles were transferred to a 37" bath for 5 inin and centrifuged at 0" for 60 min a t 12,000 rpm in the Sorvall GSA rotor. The clear amber supernatant is Fraction I (755 ml). Table 1 . Ammonium Suljafe I . Solid ammonium sulfate (0.3 g/ml of Fraction 1) was added with rapid stirring. After 20 min, the suspension was centrifuged for 10 mill a t 12,000 rpm in the GSA rotor. Pellets were successively suspended in one-fifth the volume of Fraction I in buffer I plus: (a) 0.30 g (b) 0.24 g (c) 0.22 g ( d ) 0.20 g (e) 0.18 g and ( f ) 0.16 g of ammonium sulfate per ml. Suspensions were performed with glassTeflon homogenizers and were followed at once by centrifugation for 10 min at 12,000 rpm in the GSA rotor. The supernatant from each centrifugation was mixed with an equal volume of saturated, neutralized ammonium sulfate and, after 10 min, centrifuged as before. Each precipitate was dissolved in 10 ml of buffer I1 and fractions of high specific activity (usually d-f) were pooled: Fraction I1 (44 ml).
0-4'. A summary of the purification is in
Amnionium Sulfate I I . Fraction I1 was mixed with an equal volume of saturated ammonium sulfate and centrifuged after 10 min. The centrifugation here and subsequently was for 5 rnin a t 16,000 rpm in the Sorvall SS34 rotor. Pellets were tion, the supernatants were precipitated with saturated ammonium sulfate as before. Each precipitate was dissolved in 5 ml of buffer 111; fractions of high specific activity (usually c and d ) were pooled: Fraction 111 (12 ml).
Gel Filtration I . Fraction I11 was applied to a Bio-Gel A-5m column (100-200 mesh, 240 ml) equilibrated with buffer 11.
Fractions that primed DNA synthesis on M13, but not 4X-174, SS (Fig. 1) were pooled: Fraction IV (60 ml).
Gel Filtration I I , Fraction IV was concentrated by addition of 0.3 g of solid ammonium sulfate per ml. After 30 min, the suspension was centrifuged and the precipitate was dissolved with 1.5 ml of buffer I11 (1.5 ml) and applied to a Bio-Gel A-5m column (100-200 mesh, 60 ml) equilibrated with buffer 111. Fractions of peak RNA polymerase I11 specific activity were pooled: Fraction V (14 ml). This fraction was stable for at least 2 weeks at 0".
Requirements for Specijc Priming of M1S D N A Replication.
Discrimination by RNA polymerase between M13 and 4X DNA for priming DNA synthesis requires two factors: ( i ) the novel form of RNA polymerase, designated RNA polymerase I11 to distinguish it from the classic holoenzyme, called RNA polymerase I, and ( i i ) DNA unwinding protein in an amount sufficient to coat the single-stranded DNA (Table 2 ). The unwinding protein markedly stimulates the RNA polymerase I-prinied reaction (6) but does so for both M13 and 4X DNA replication; the effect on the RNA polymerase 111-primed reaction is to suppress specifically the 4X DNA replication. R N A polymerase I I I has feeble transcriptional actirily. RNA polymerase I11 was 15-to 70-fold less active than RNA4 polymerase I in transcription of standard templates, such as A, T4, and salmon sperm DNA, and poly[d(h-T)] (Table 3) . When the two polymerases were present in the same incubation, the RNA polymerase I remained active, thus indicating the absence of a diffusible inhibitor to account for the inactivity of RN.4 polymerase 111. then precipitated with ammonium sulfate to separate proteins from free, unbound rifampicin was inactive in priming DNA, but when mixed with RNA polymerase I prevented it from priming $X SS while still permitting it to prime M13. This result suggested that rifampicin released a factor from RNA polymerase 111 that could confer the M13-specificity property on RNA polymerase I. This diffusible factor, released by rifampicin, nas isolated by Sephades G-150 gel filtration (Fig. 2) , using as an assay its inhibition of the priming of $X DNA synthesis by RNA polymerase I. Little or none of this factor activity was seen on gel filtration in a control experiment with RNA polyinerase 111 that had not been exposed to rifampicin. As judged by gel filtration, the factor is smaller than hemoglobin, but its size and other properties remain to be determined.
The rifampicin-induced release of a diffusible factor was also studied with the aid of a rifampicin-resistant RNA polymerase I (I-rifR) ( Table 5 ). When I-rifR was mixed with RNA polymerase I11 in the absence of rifampicin (Esps. 1,3, and 5), RNA-primed DNA synthesis and transcription showed ap- Holoenzyme and core RNA polymerase I, RNA polymerase I prepared by the method of Babinet (ll), and Fraction IV RNA polymerase I11 (0.007 unit) were assayed as described in Matetials and Melhods. Where indicated, the enzyme was incubated for 5 min at 0 ' with 6 a / m l of rifampicin before addition to the assay.
* Holoenzyme RNA polymerase I has been purified by an unpublished procedure employing phosphocellulose chromatography (Prof. M. Chamberlin and Dr. N. Gonzalez, University of California, Berkeley).
proximately additive results. In contrast, when rifampicintreated RNA polymerase I11 was mixed with RNA polymerase I (Exps. 2, 4, and 6), the priming of $X replication was depressed whereas that of hI13 was stimulated: RNA Isolation of a factor released from RNA polymerase I11 by rifampicin. Samples of RNA polymerase I11 (100 pg in 0.1 ml buffer 111) were incubated for 5 min at 0" ( A ) with rifampicin (2 pg) or ( B ) without the drug. Each sample was then mixed with 100 fil of saturated ammonium sulfate. After 10 min at Oo, the precipitates were collected by centrifugation (OO, 5 min, 16,000 rpm in the Sorvall SE12 rotor). Each precipitate was suspended twice in 3 ml of a mixture of equal volumes of buffer I and saturated ammonium sulfate and collected by centrifugation (as above). Rifampicin-treated (sample A ) and untreated RNA polymerase I11 (sample B), dissolved in 100 pl buffer I were each filtered over a Sephadex G-150 column (0.6 X 8 cm, equilibrated with buffer I at 4'). Aliquots (3 p l ) of the 1Wp1 fractions were assayed for their ability t o inhibit RNA polymerase I-primed C p X SS -+ RF. Incorporation of 20 pmoles of deoxynucleotide into the acid-insoluble fraction was observed in the uninhibited reaction.
Proc. Nat. Acad. Sci. U S A 71 (2974) Rifampicin-resistant RNA polymerase I (I-rifn, 1 pg) and RNA polymerase I11 (2 pg, rifampicin-sensitive) were assayed as described in M~c r i u l s and Methods. Where indicated, the enzymes were incubated for 5 min at 0" with 2 pg of rifampicin per ml. synthesis on a T4 duplex DNA template was likewise depresed upon mising of the two rifampicin-treated enzymes.
In sum, rifampicin, known to act on the p subunit, appears to release a small factor from RNA polymerase 111, which can cause RNA polymerase I to discriminate between M13 and +X SS and to become relatively incrt in transcript.ion of duplei DNA.
DISCUSSION
The capacity of cell extracts to discriminate in the replication of M13 and #X single-stranded DNA in a rifampioiii-sensitive reactioi! was not maintained in a purified RNA polymerasemultienzyme system. Our efforts to restore discriminatory ability to the purified system have led us to a new form of RNA polymerase, termed RNA polymerase 111. This enzyme is physically separable from RNA polymerase I (Fig. 1) and is further recognized by (i) its selective abilit,y to prime the replication of M13, but not #X DNA, and (ii) its inability to transcribe standard duples DNA. The close relation of RNA polymerase 111 to RNA polymerase I is shown by its sensitivity to rifampicin. Upon exposure to rifampicin, RNA polymerase I11 releases a factor, presumably a low-molecularweight subunit, that inhibits RNA polymerase I transcription and confers the aLility to prime M1.3 hut not #X replicat.ion. This factor may be the major difference between RNA polymerases I and 111.
Modification of RNA polynierase functions by addition or substitution of subunits has been shown in phage T 3 and T4
infections of E. coli (14, 15) and in SP82 infection of B. szrhtilis (16). Chao and Speyer (17) found that E. coli RNA polymerase is chaiiged in chromatographic properties and teniplate specificity \vheii cells ent,er a stat'ionary phase. However, this form of RNA polymerase is not separated from REA polymerase I by gel filtration and, while inactive ill t,ranscriptioii of natural duples DNA, it, is still quite active on poly[d(A-T)]. In contrast, RNA polymerase I11 has been obtained from cells growing esponentially, is separable from
